The
FDA has released a draft guidance that details
the agency's proposal on the nonproprietary naming of biological products,
according to a recent blog post on FDA
Voice.
Posted by Tim Sandle
Microbiology, pharmaceuticals, healthcare and contamination control news and discussion site. Edited by Dr. Tim Sandle (established 2010)
No comments:
Post a comment
Pharmaceutical Microbiology Resources